{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:27:15Z","timestamp":1791322035378,"version":"4.3.1"},"reference-count":63,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2008,10,29]],"date-time":"2008-10-29T00:00:00Z","timestamp":1225238400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0003433","type":"journal-article","created":{"date-parts":[[2008,10,28]],"date-time":"2008-10-28T20:18:02Z","timestamp":1225225082000},"page":"e3433","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":50,"title":["Estimating the Extent of Vaccine-Derived Poliovirus Infection"],"prefix":"10.1371","volume":"3","author":[{"given":"Alison","family":"Wringe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E. M.","family":"Fine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland W.","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olen M.","family":"Kew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2008,10,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"8366","DOI":"10.1128\/JVI.77.15.8366-8377.2003","article-title":"Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993.","volume":"77","author":"CF Yang","year":"2003","journal-title":"J Virol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1006\/viro.1999.0003","article-title":"Evolution of poliovirus type I during 5.5 years of prolonged enteral replication in an immunodeficient patient.","volume":"265","author":"A Bellmunt","year":"1999","journal-title":"Virology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1128\/JCM.36.10.2893-2899.1998","article-title":"Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient.","volume":"36","author":"OM Kew","year":"1998","journal-title":"J Clin Microbiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.1128\/JVI.74.16.7381-7390.2000","article-title":"Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model.","volume":"74","author":"GV Gavrilin","year":"2000","journal-title":"J Virol"},{"key":"ref5","first-page":"913","article-title":"(2003) Laboratory surveillance for wild and vaccine-derived polioviruses, January 2002\u2013June 2003.","volume":"52","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref6","first-page":"133","article-title":"(2002) Expanding contributions of the global laboratory network for poliomyelitis eradication, 2000\u20132001.","volume":"77","year":"2002","journal-title":"Wkly Epidemiol Rec"},{"key":"ref7","first-page":"1093","article-title":"(2006) Update on vaccine-derived polioviruses.","volume":"55","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1086\/506359","article-title":"An outbreak of poliomyelitis caused by type 1 vaccine-derived poliovirus in China.","volume":"194","author":"X Liang","year":"2006","journal-title":"J Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"13512","DOI":"10.1128\/JVI.78.24.13512-13521.2004","article-title":"Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001.","volume":"78","author":"H Shimizu","year":"2004","journal-title":"J Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3201\/eid0907.020692","article-title":"Recombinant vaccine-derived poliovirus in Madagascar.","volume":"9","author":"D Rousset","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/525049","article-title":"A large vaccine-derived poliovirus outbreak on Madura Island\u2013Indonesia, 2005.","volume":"197","author":"CF Estivariz","year":"2008","journal-title":"J Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1126\/science.1068284","article-title":"Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus.","volume":"296","author":"O Kew","year":"2002","journal-title":"Science"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1086\/587694","article-title":"Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar.","volume":"197","author":"M Rakoto-Andrianarivelo","year":"2008","journal-title":"J Infect Dis"},{"key":"ref14","first-page":"996","article-title":"(2007) Update on vaccine-derived polioviruses\u2013worldwide, January 2006\u2013August 2007.","volume":"56","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref15","first-page":"181","article-title":"Molecular epidemiology of type 2 vaccine-associated paralytic poliomyelitis in china.","volume":"56","author":"Y Chiba","year":"2003","journal-title":"Jpn J Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1128\/JVI.76.13.6791-6799.2002","article-title":"Long-term circulation of vaccine-derived poliovirus that causes paralytic disease.","volume":"76","author":"EA Cherkasova","year":"2002","journal-title":"J Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"7758","DOI":"10.1128\/JVI.71.10.7758-7768.1997","article-title":"Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis.","volume":"71","author":"MM Georgescu","year":"1997","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1128\/JCM.38.10.3729-3734.2000","article-title":"Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel.","volume":"38","author":"LM Shulman","year":"2000","journal-title":"J Clin Microbiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1371\/journal.pone.0000069","article-title":"Neurovirulent vaccine-derived polioviruses in sewage from highly immune populations.","volume":"1","author":"LM Shulman","year":"2006","journal-title":"PLoS ONE"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1128\/JVI.78.9.4876-4883.2004","article-title":"Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia.","volume":"78","author":"S Blomqvist","year":"2004","journal-title":"J Virol"},{"key":"ref21","first-page":"47","article-title":"Polio control after certification: major issues outstanding.","volume":"82","author":"PE Fine","year":"2004","journal-title":"Bull World Health Organ"},{"key":"ref22","first-page":"129","article-title":"Stopping a polio outbreak in the post-eradication era.","volume":"105","author":"PE Fine","year":"2001","journal-title":"Dev Biol (Basel)"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/j.1539-6924.2006.00844.x","article-title":"Containment of polioviruses after eradication and OPV cessation: characterizing risks to improve management.","volume":"26","author":"W Dowdle","year":"2006","journal-title":"Risk Anal"},{"key":"ref24","article-title":"Poliovirus vaccine- live.","author":"R Sutter","year":"2003"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/oxfordjournals.aje.a121457","article-title":"Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference.","volume":"96","author":"TJ John","year":"1972","journal-title":"Am J Epidemiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0140-6736(07)60531-5","article-title":"Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study.","volume":"369","author":"NC Grassly","year":"2007","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/clinids\/13.5.926","article-title":"Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review.","volume":"13","author":"PA Patriarca","year":"1991","journal-title":"Rev Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"S371","DOI":"10.1093\/clinids\/6.Supplement_2.S371","article-title":"Some observations on poliomyelitis lameness surveys.","volume":"2","author":"RH Bernier","year":"1984","journal-title":"Rev Infect Dis 6 Suppl"},{"key":"ref29","first-page":"207","article-title":"Development of neutralizing antibodies against the three types of poliomyelitis virus during an epidemic period; the ratio of inapparent infection to clinical poliomyelitis.","volume":"58","author":"JL Melnick","year":"1953","journal-title":"Am J Hyg"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1128\/JVI.74.7.3001-3010.2000","article-title":"Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion.","volume":"74","author":"J Mart\u00edn","year":"2000","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"12623","DOI":"10.1128\/JVI.79.20.12623-12634.2005","article-title":"Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient.","volume":"79","author":"CF Yang","year":"2005","journal-title":"J Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1128\/JVI.02354-07","article-title":"Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range.","volume":"82","author":"J Jorba","year":"2008","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/oxfordjournals.aje.a009924","article-title":"Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative.","volume":"150","author":"PE Fine","year":"1999","journal-title":"Am J Epidemiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/clinids\/14.2.568","article-title":"Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease.","volume":"14","author":"PM Strebel","year":"1992","journal-title":"Clin Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1093\/infdis\/175.Supplement_1.S165","article-title":"Outbreaks of paralytic poliomyelitis, 1976\u20131995.","volume":"1","author":"PA Patriarca","year":"1997","journal-title":"J Infect Dis 175 Suppl"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/oxfordjournals.aje.a112848","article-title":"The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance.","volume":"110","author":"N Nathanson","year":"1979","journal-title":"Am J Epidemiol"},{"key":"ref37","first-page":"367","article-title":"Studies on the development of natural immunity to poliomyelitis in Louisiana. II. Description and analysis of episodes of infection observed in study group households.","volume":"65","author":"HM Gelfand","year":"1957","journal-title":"Am J Hyg"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1128\/JVI.69.8.4972-4978.1995","article-title":"Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine.","volume":"69","author":"MJ Bouchard","year":"1995","journal-title":"J Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1128\/JVI.65.3.1377-1382.1991","article-title":"Identification of two determinants that attenuate vaccine-related type 2 poliovirus.","volume":"65","author":"RB Ren","year":"1991","journal-title":"J Virol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1128\/JVI.63.3.1338-1344.1989","article-title":"Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine.","volume":"63","author":"GD Westrop","year":"1989","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1128\/JVI.63.11.4949-4951.1989","article-title":"Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine.","volume":"63","author":"SR Pollard","year":"1989","journal-title":"J Virol"},{"key":"ref42","first-page":"33","article-title":"Risk of vaccine-associated paralytic poliomyelitis in Latin America, 1989\u201391.","volume":"73","author":"JK Andrus","year":"1995","journal-title":"Bull World Health Organ"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jama.1987.03390100073029","article-title":"Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984.","volume":"257","author":"BM Nkowane","year":"1987","journal-title":"Jama"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/bmj.305.6845.79","article-title":"Paralytic poliomyelitis in England and Wales, 1985\u201391.","volume":"305","author":"R Joce","year":"1992","journal-title":"Bmj"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1590\/S1020-49892000000400002","article-title":"Vaccine-associated paralytic poliomyelitis in Brazil, 1989\u20131995.","volume":"7","author":"LH de Oliveira","year":"2000","journal-title":"Rev Panam Salud Publica"},{"key":"ref46","first-page":"210","article-title":"Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine.","volume":"80","author":"KA Kohler","year":"2002","journal-title":"Bull World Health Organ"},{"issue":"(Pt 5)","key":"ref47","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1099\/0022-1317-69-5-1091","article-title":"The effect of sequences in the 5\u2032 non-coding region on the replication of polioviruses in the human gut.","volume":"69","author":"PD Minor","year":"1988","journal-title":"J Gen Virol"},{"key":"ref48","first-page":"855","article-title":"(2001) Update: Outbreak of poliomyelitis\u2013Dominican Republic and Haiti, 2000\u20132001.","volume":"50","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1086\/382545","article-title":"Isolation and characterization of circulating type 1 vaccine-derived poliovirus from sewage and stream waters in Hispaniola.","volume":"189","author":"J Vinj\u00e9","year":"2004","journal-title":"J Infect Dis"},{"key":"ref50","article-title":"(2008) Core Health Indicators.","year":"2008"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/oxfordjournals.aje.a120717","article-title":"Studies of the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter.","volume":"86","author":"M Benyesh-Melnick","year":"1967","journal-title":"Am J Epidemiol"},{"key":"ref52","first-page":"252","article-title":"(2003) Progress toward poliomyelitis eradication\u2013Egypt, 2002.","volume":"52","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref53","first-page":"820","article-title":"(2004) Progress towards poliomyelitis eradication - Egypt, 2003\u20132004.","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref54","article-title":"UN-Habitat Population Statistics."},{"key":"ref55","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1093\/infdis\/175.Supplement_1.S56","article-title":"The eradication of poliomyelitis in Egypt: critical factors affecting progress to date.","volume":"1","author":"RB Aylward","year":"1997","journal-title":"J Infect Dis 175 Suppl"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication.","volume":"59","author":"OM Kew","year":"2005","journal-title":"Annu Rev Microbiol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"12460","DOI":"10.1128\/JVI.77.23.12460-12465.2003","article-title":"Retrospective analysis of a local cessation of vaccination against poliomyelitis: a possible scenario for the future.","volume":"77","author":"EA Korotkova","year":"2003","journal-title":"J Virol"},{"key":"ref58","first-page":"72","article-title":"Hypogammaglobulinaemia in the United Kingdom. VII. The role of humoral antibodies in protection against and recovery from bacterial and virus infections in hypogammaglobulinaemia.","volume":"310","author":"FO MacCallum","year":"1971","journal-title":"Spec Rep Ser Med Res Counc (G B)"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0140-6736(04)16150-3","article-title":"Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man.","volume":"363","author":"C MacLennan","year":"2004","journal-title":"Lancet"},{"key":"ref60","first-page":"347","article-title":"Stopping poliovirus vaccination after eradication: issues and challenges.","volume":"78","author":"DJ Wood","year":"2000","journal-title":"Bull World Health Organ"},{"key":"ref61","first-page":"1053","article-title":"(2003) Poliovirus infections in four unvaccinated children\u2013Minnesota, August\u2013October 2005.","volume":"54","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref62","first-page":"874","article-title":"(2001) Acute flaccid paralysis associated with circulating vaccine-derived poliovirus\u2013Philippines, 2001.","volume":"50","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref63","article-title":"(2005) Poliomyelitis surveillance weekly bulletin. Polio Weekly Bulletin","year":"2005"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0003433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T16:22:30Z","timestamp":1589041350000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0003433"}},"subtitle":[],"editor":[{"given":"Jose","family":"Esparza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,10,29]]},"references-count":63,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2008,10,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0003433","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,29]]}}}